In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
bowl of edamame
Does Eating Soy Increase Estrogen and Cause Breast Cancer?

Learn whether eating soy products causes cancer.
Shanu Modi
In the Clinic
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)

On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Sir Murray Brennan and Bob Li wearing white coats and posing for a photo outside
The War on Cancer Must Be Global: MSK Experts Promote More Collaboration at Forbes China Summit

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.
A chess match
In the Lab
Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy

New research on an experimental drug provides hope for better responses to immunotherapy.
3D illustration of a heart
Q&A
Breast Cancer Treatment and the Risk of Heart Disease: What to Know

The American Heart Association recently issued a statement about the risk of cardiovascular disease for women with breast cancer.
Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.
Finding
Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.
Joan Massagué leads Memorial Sloan Kettering's Metastasis Research Center
Opening Cancer's Black Box

The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment.
Sisters Jo and Jan Claire Luzarraga are seen smiling.
MSK’s Expertise in Caring for Younger Adults With Cancer

Learn about MSK's expertise and compassion in caring for people under 50 who are facing cancer.
Close up photo of three pill types
Q&A
What's Become of AIDS-Related Cancers?

Several types of cancer were once strongly linked to an AIDS diagnosis. Thanks to improved HIV medications, that's changing.